Inventor · disambiguated record
John Demattei
Also filed as: DEMATTEI JOHN · DEMATTEI JOHN A
26 granted patents·11 pending applications·712 citations·filing 1998–2021
97Inventor score
Top patents by PatentIndex Score
37 records- 0198US8765957B2Process for making modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2013·Granted Jul 1, 2014·73 cites·3 claims
- 0298US8623894B2Solid forms of N-[2,4-Bis(1,1-dimethyethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquioline-3-carboxamideVERTEX PHARMA·Filed 2012·Granted Jan 7, 2014·76 cites·3 claims
- 0398US8362253B2Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamideVERTEX PHARMA·Filed 2012·Granted Jan 29, 2013·95 cites·11 claims
- 0497US9751839B2Process for making modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2016·Granted Sep 5, 2017·41 cites·3 claims
- 0597US9371287B2Process for making modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2014·Granted Jun 21, 2016·55 cites·29 claims
- 0697US8835639B2Process for making modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2012·Granted Sep 16, 2014·72 cites·28 claims
- 0797US8163772B2Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxypheny1]-1,4-dihydro-4-oxoquinoline-3-carboxamideDEMATTEI JOHN·Filed 2008·Granted Apr 24, 2012·119 cites·56 claims
- 0896US8476442B2Process for making modulators of cystic fibrosis transmembrane conductance regulatorDEMATTEI JOHN·Filed 2010·Granted Jul 2, 2013·89 cites·13 claims
- 0995US11149292B2Processes for the preparation of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[B]indol-3-yl)acetic acid and salts thereofARENA PHARM INC·Filed 2016·Granted Oct 19, 2021·8 cites·21 claims
- 1093US9447041B2Processes for the preparation of (R)-2-(7-4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[B]indol-3-yl)acetic acid and salts thereofARENA PHARM INC·Filed 2015·Granted Sep 20, 2016·12 cites·22 claims
- 1192US9175320B2Processes for the preparation of (R)-2-(7-4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[B]indol-3-yl)acetic acid and salts thereofARENA PHARM INC·Filed 2014·Granted Nov 3, 2015·15 cites·42 claims
- 1289US10618896B2Alkyl chain modified imidazoquinoline TLR7/8 agonist compounds and uses thereofDYNAVAX TECH CORP·Filed 2018·Granted Apr 14, 2020·4 cites·15 claims
- 1388US8853419B2Processes for the preparation of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid and salts thereofMONTALBAN ANTONIO GARRIDO·Filed 2011·Granted Oct 7, 2014·17 cites·24 claims
- 1484US9156795B2Hydrogen sulfate saltDEMATTEI JOHN·Filed 2012·Granted Oct 13, 2015·9 cites·20 claims
- 1581US6579986B2Preparation of quinoline-substituted carbonate and carbamate derivativesABBOTT LAB·Filed 2002·Granted Jun 17, 2003·8 cites·5 claims
- 1676US11674163B2Processes for the preparation of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid and salts thereofARENA PHARM INC·Filed 2021·Granted Jun 13, 2023·0 cites·15 claims
- 1773US8952197B2Processes for the preparation of 5-HT2C receptor agonistsDEMATTEI JOHN A·Filed 2010·Granted Feb 10, 2015·3 cites·44 claims
- 1871US6417366B2Preparation of quinoline-substituted carbonate and carbamate derivativesABBOTT LAB·Filed 2000·Granted Jul 9, 2002·4 cites·22 claims
- 1967US8039637B2Process for preparing benzimidazole compoundsARRAY BIOPHARMA INC·Filed 2006·Granted Oct 18, 2011·1 cites·7 claims
- 2065US2014350281A1Process for making modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2014·Application pending·0 cites
- 2164US2017327456A1Process for making modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2017·Application pending·0 cites
- 2260US9024040B2Processes for preparing benzimidazole compoundsDEMATTEI JOHN·Filed 2012·Granted May 5, 2015·0 cites·11 claims
- 2359US2012122921A1Process for making modulators of cystic fibrosis transmembrane conductance regulatorDEMATTEI JOHN·Filed 2011·Application pending·0 cites
- 2457US8501956B2Benzimidazole compoundsDEMATTEI JOHN·Filed 2011·Granted Aug 6, 2013·0 cites·4 claims
- 2557US8383832B2Process for preparing benzimidazole compoundsARRAY BIOPHARMA INC·Filed 2011·Granted Feb 26, 2013·0 cites·7 claims
- 2656US2014221443A1Novel hydrogen sulfate saltASTRAZENECA AB·Filed 2014·Application pending·0 cites
- 2755US2010016393A1Novel hydrogen sulfate saltDEMATTEI JOHN·Filed 2006·Application pending·0 cites
- 2853US2006128962A1Preparation of quinoline-substituted carbonate and carbamate derivativesALLEN MICHAEL S·Filed 2006·Application pending·0 cites
- 2952US5981521ATetrahydroisoquinoline derivatives as LHRH antagonistsABBOTT LAB·Filed 1998·Granted Nov 9, 1999·11 cites·20 claims
- 3051US9562017B2Hydrogen sulfate saltARRAY BIOPHARMA INC·Filed 2015·Granted Feb 7, 2017·0 cites·21 claims
- 3150US2015210625A1Processes for the preparation of 5-ht2c receptor agonistsDEMATTEI JOHN A·Filed 2014·Application pending·0 cites
- 3247US2010292288A1Crystalline forms of (r)-1-{2-[4`- (3-methoxy-propane-1- sulfonyl)-biphenyl-4-yl]-ethyl}-2-methyl-pyrrolidine, and compositions, and methods related theretoARENA PHARM INC·Filed 2008·Application pending·0 cites
- 3345US8183385B2SNAR process for preparing benzimidazole compoundsDEMATTEI JOHN·Filed 2006·Granted May 22, 2012·0 cites·39 claims
- 3445US7074932B2Preparation of quinoline-substituted carbonate and carbamate derivativesALLEN MICHAEL S·Filed 2003·Granted Jul 11, 2006·0 cites·2 claims
- 3539US2007276145A1Method of Preparing a Ring Compound Having Two Adjacent Chiral CentersICOS CORP·Filed 2004·Application pending·0 cites
- 3637US2003055297A1Process for the preparation of substituted pyrrolidine neuraminidase inhibitorsFiled 2002·Application pending·0 cites
- 3734US2012225937A1Crystalline forms and processes for the preparation of pg12 receptor agonistsBLACKBURN ANTHONY C·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when John Demattei files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →